Reporting Owner Activity for CANTEX PHARMACEUTICALS, INC.

Identity
Location
Weston, FL
SEC ownership signals
SEC record
Signature
/s/ Juan F. Rodriguez, Chief Financial Officer
SEC evidence

Follow Filing Activity

Follow CANTEX PHARMACEUTICALS, INC. and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Key facts

  • CANTEX PHARMACEUTICALS, INC. has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $3,343,550.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: CHIMERIX INC ($3,343,550).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Reported issuer positions for CANTEX PHARMACEUTICALS, INC.

CMRX Forms 3/4/5

CHIMERIX INC

Relationship
10%+ Owner
Holdings value
$3,343,550
Past year net change
Change %
Report period
14 Sep 2021

Insider Transactions Reported by CANTEX PHARMACEUTICALS, INC.:

Sym Company Class Transaction % Reported value Reported price Shares Shares after Date Ownership
An asterisk next to the price means the reported price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .